Navigation Links
PCL Guide Arm

ProductsPCL Guide Arm
Company Linvatec Corporation (now ConMed)
Item PCL Guide Arm
Features 
  • Allows advancement with a proactive stop to prevent drilling beyond the tibia and into neurovascular structures
  • Other components available
  • Description Part of the GraFix® Cruciate Reconstruction System, which is designed to facilitate arthroscopic anterior cruciate ligament reconstructions.
    Info Linvatec Corporation (now ConMed)
    Customer Service: (800) 237-0169
    Web site: http://www.conmed.com/linvatec.php

    Related medicine products :

    1. Clayman Guide
    2. OmniSight Image Guided Surgery System
    3. DeMartel (Bailey) Wire Saw Guide
    4. MIS Distal Femoral Alignment/Saw Guide and Intramedullary Rod
    5. MIS Tibial Saw Guide
    6. Tibial Alignment Guide Assembly
    7. MIS Proximal Tibial Alignment Guide
    8. PT2LS Guide Wire (light support)
    9. PT2MS Guide Wire (moderate support)
    10. Trooper Extra Support Guide Wire
    11. Tapered TEFCOR Movable Core Wire Guides
    ... determination of Ang II is ... the pharmacological effect and efficiency ... angiotensin converting enzyme inhibitors (ACE ... antagonists as well as for ...
    ... antigen test is a visual ... presumptive qualitative detection of Respitory ... specimens in neonatal and pediatric ... test has a built-in procedural ...
    Rapid Immunoassay for the detection of Respiratory Syncytial Virus....
    ... BD Directigen EZ RSV Test utilizes a new, ... one device for rapid RSV detection. The testing ... method whereby dried reagents have already been applied ... a two-step process, with clear-cut results shown by ...
    Medicine Products:
    (Date:7/6/2015)... ... July 06, 2015 , ... ... Medical Spa industries, announces the return of its complimentary educational webinar series ... aesthetic medical business leaders creates success for their clients through targeted marketing, sales, ...
    (Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... fat-reduction procedures each year for aesthetic reasons, which is why liposuction regularly ranks ... a particular demographic, however, fat reduction has become more than a way to ...
    (Date:7/6/2015)... Vancouver, BC (PRWEB) , ... July 06, 2015 , ... ... has received the UBC 2014-2015 Post Graduate Teaching Award on behalf of the department ... Endocrinology is a very exciting field to be practicing in. The technology is changing ...
    (Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... doTERRA, the ... to its executive management team. Most recently, Jowers held the position as Director of ... years. , After spending a decade building the institute, Jowers states that he was ...
    (Date:7/6/2015)... ... July 06, 2015 , ... ... allows newly-diagnosed cancer patients, caregivers and medical professionals to chat with the CHN ... same cancer. , “Receiving a cancer diagnosis is often the most traumatic experience ...
    Breaking Medicine News(10 mins):Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 3Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 3Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 3Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 4Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2
    ... AGA Medical Corporation ("AGA,Medical") announced today that it ... and Welfare (MHLW) for its AMPLATZER(R) Duct Occluder ... used for the,non-surgical closure of patent ductus arteriosus ... occurs when a blood vessel known as the ...
    ... Medical Innovations, Inc. (NYSE: IMA ), a ... solutions, has introduced the pima(TM) analyzer, a ... The initial application of the instrument will be a ... instrument is one of several novel technologies under development ...
    ... national health care reform a top priority of the ... proposals swirling about Washington, D.C., and around the country, ... stepping up its efforts to identify and launch new ... care delivery systems.With health care reform a central feature ...
    ... awareness and knowledge of Daiichi Sankyo,s innovative treatmentsPARSIPPANY, N.J., ... it has established a subsidiary -- Daiichi Sankyo de ... Inc. is based in San Juan, and led by ... more than 20 years of experience in pharmaceutical sales ...
    ... FDA-approved once-daily amoxicillin will be promoted to health ... Pharmaceuticals, Inc. (Nasdaq: MBRK ), today ... extended-release) Tablets, 775mg, will begin on March 16, ... of its 270-person field force which will promote ...
    ... - Hard to Treat Diseases (HTDS) www.htdsmedical.com ... identified a cosmetics company as a potential merger candidate. ... is engaged in online sales of the "Melem" product. ... It has a wide variety of skin and lip ...
    Cached Medicine News:Health News:AGA Medical Receives Japanese Approval for AMPLATZER(R) Duct Occluder 2Health News:AGA Medical Receives Japanese Approval for AMPLATZER(R) Duct Occluder 3Health News:Inverness Medical Innovations Presents the pima(TM) Point-of-Care CD4 Instrument at ICASA 2008 2Health News:Inverness Medical Innovations Presents the pima(TM) Point-of-Care CD4 Instrument at ICASA 2008 3Health News:Newly Reactivated Health Economics Research Institute to Launch New Initiatives for Improving Health Care Delivery 2Health News:Newly Reactivated Health Economics Research Institute to Launch New Initiatives for Improving Health Care Delivery 3Health News:Daiichi Sankyo, Inc. Establishes Subsidiary in Puerto Rico 2Health News:MiddleBrook Pharmaceuticals to Launch Moxatag(TM) March 2009 2Health News:MiddleBrook Pharmaceuticals to Launch Moxatag(TM) March 2009 3Health News:MiddleBrook Pharmaceuticals to Launch Moxatag(TM) March 2009 4Health News:Hard To Treat Diseases (HTDS) Set To Acquire Cosmetics Company 2
    (Date:7/6/2015)... HAYWARD, Calif. , July 6, 2015  Impax ... Larry Hsu , Ph.D. has resigned from the ... business activities. Dr. Hsu was a co-founder of Impax ... Chief Executive Officer from October 2006 until April 2014. ... Fred Wilkinson , Impax,s President and Chief Executive ...
    (Date:7/6/2015)... , July 6, 2015 Akcea Therapeutics, ... ISIS ), announced today that the U.S. ... Designation to volanesorsen (ISIS-APOCIII Rx ) for the ... FCS is a rare genetic disease characterized by ... In a Phase 2 study published in the ...
    (Date:7/6/2015)... , July 6, 2015 /PRNewswire/ -- China Nepstar Chain Drugstore ... a leading retail drugstore chain in China ... stores, today announced that its board of directors has ... 2015, from Simin Zhang , chairman of the ... Drugstore Holding Ltd., an investment vehicle wholly owned by ...
    Breaking Medicine Technology:Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 2Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 3Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 4Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 2China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 3China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 4China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 5China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 6